Baillie Gifford & Co. Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Baillie Gifford & Co. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 3,848,547 shares of the medical equipment provider’s stock after buying an additional 24,183 shares during the period. Intuitive Surgical accounts for approximately 1.4% of Baillie Gifford & Co.’s holdings, making the stock its 19th biggest position. Baillie Gifford & Co.’s holdings in Intuitive Surgical were worth $1,890,676,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Vanguard Group Inc. raised its stake in Intuitive Surgical by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after purchasing an additional 493,126 shares during the period. Capital World Investors lifted its holdings in shares of Intuitive Surgical by 1.0% in the first quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after buying an additional 73,634 shares in the last quarter. American Century Companies Inc. grew its stake in Intuitive Surgical by 3.0% during the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after acquiring an additional 70,556 shares in the last quarter. Clearbridge Investments LLC increased its holdings in Intuitive Surgical by 1.6% in the 2nd quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock valued at $881,380,000 after acquiring an additional 30,449 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in Intuitive Surgical by 15.4% in the 2nd quarter. Assenagon Asset Management S.A. now owns 1,483,406 shares of the medical equipment provider’s stock worth $659,893,000 after purchasing an additional 197,841 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Barclays lifted their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Morgan Stanley lifted their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Royal Bank of Canada boosted their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Stock Down 0.1 %

Shares of Intuitive Surgical stock opened at $535.75 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $281.12 and a 52 week high of $542.59. The company has a market capitalization of $190.82 billion, a PE ratio of 86.13, a price-to-earnings-growth ratio of 5.27 and a beta of 1.39. The stock’s fifty day moving average is $494.78 and its two-hundred day moving average is $453.94.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In related news, General Counsel Gary Loeb sold 300 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now owns 1,595 shares in the company, valued at approximately $757,625. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares in the company, valued at approximately $757,625. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 68,006 shares of company stock valued at $33,727,766. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.